Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJJKR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,050
Award facts
- Contract value 100% obligated
- $15,049.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,049.86 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) on July 17, 2025, with an ultimate completion date of July 18, 2025. This firm fixed price, competitively awarded delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the company's ability to compete successfully in open federal procurement.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The SPE2DX indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains. This delivery order for Gemtesa, a specialty medication, exemplifies the company's role in fulfilling ongoing pharmaceutical supply needs for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJJKR?
SPE2DB25FJJKR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FJJKR worth?
The government has obligated $15,050 on SPE2DB25FJJKR.
Is contract SPE2DB25FJJKR an order under another contract?
Yes. SPE2DB25FJJKR is a delivery order under SPE2DB24D2102, an indefinite delivery contract.
Was contract SPE2DB25FJJKR competed?
The extent of competition for SPE2DB25FJJKR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award